Margaret Tisdale

Margaret Tisdale

UNVERIFIED PROFILE

Are you Margaret Tisdale?   Register this Author

Register author
Margaret Tisdale

Margaret Tisdale

Publications by authors named "Margaret Tisdale"

Are you Margaret Tisdale?   Register this Author

13Publications

-Reads

Virus susceptibility analyses from a phase IV clinical trial of inhaled zanamivir treatment in children infected with influenza.

Antimicrob Agents Chemother 2013 Apr 18;57(4):1677-84. Epub 2013 Jan 18.

GlaxoSmithKline R&D, Stevenage, United Kingdom.

View Article
April 2013

Human immunodeficiency virus type 1 reverse transcriptase mutation selection during in vitro exposure to tenofovir alone or combined with abacavir or lamivudine.

Antimicrob Agents Chemother 2004 Apr;48(4):1413-5

International Clinical Virology, Medicines Research Centre, GlaxoSmithKline Research and Development, Stevenage, Hertfordshire SG1 2NY, United Kingdom.

View Article
April 2004

Differentiation of genotypic resistance profiles for amprenavir and lopinavir, a valuable aid for choice of therapy in protease inhibitor-experienced HIV-1-infected subjects.

J Antimicrob Chemother 2003 Sep 13;52(3):319-23. Epub 2003 Aug 13.

Department of International Clinical Virology, GlaxoSmithKline Inc., 5 Moore Drive, Research Triangle Park, NC 27709, USA.

View Article
September 2003

Characterization of 2 influenza A(H3N2) clinical isolates with reduced susceptibility to neuraminidase inhibitors due to mutations in the hemagglutinin gene.

J Infect Dis 2002 Oct 30;186(8):1074-80. Epub 2002 Sep 30.

Research Center in Infectious Diseases of the CHUQ-CHUL and Laval University, Quebec City, Quebec, Canada.

View Article
October 2002